It's the same story from IBM
In the face of a possible American recession, Big Blue delivered 28% earnings growth on 13% higher revenue, based on balanced performance across the globe in various product categories, with a healthy mix of supporting services. $26.8 billion in sales is nothing to sneeze at, nor is $1.98 of earnings per share for an earnings yield of 6.3% at the current run rate. Good luck finding a savings account with that kind of return on your invested capital.
And it looks like the success story will continue. "We entered the second quarter with a strong deal pipeline and this quarter, frankly, we were sold out," said CFO Mark Loughridge. Large contracts with pharma giant Pfizer
One of the biggest tech businesses in the world has completely filled its order book? Now that’s a nice problem to have. Keep looking for trouble, IBM.
Fool contributor Anders Bylund holds no position in any of the companies discussed here. You can check out Anders' holdings if you like, and Foolish disclosure is always looking for the right kind of trouble.